Tatiana Dimitriadi (Russian Federation)
Regional Consulting Diagnostic center Regional cervical pathology centerPresenter of 1 Presentation
IMPLEMENTATION OF SECONDARY CERVICAL CANCER PREVENTION IN THE REGIONAL CENTER OF CERVICAL PATHOLOGY. (ID 18)
Abstract
Introduction
Objective. To analyse the application of the methods of cervical cancer (CC) prevention in the Regional center cervical pathology (RCCP) Rostov-on-don.
Methods
In 2008, the Regional center of cervical pathology (RCCP) was organized on the basis of the clinical and laboratory complex of the Regional consultative diagnostic center (OCDC) in Rostov-on-don, where the office of human papillomavirus (HPV) vaccination began its work. In 2012 the program of CC screening with the method of liquid-based cytology was introduced for the first time in Russia. It covered 54 medical organizations of the Rostov region (RR). HPV positive patients with abnormal PAP smears are invited to RCCP for making a diagnosis and treatmenLiquid base cytology, the HPV test PCR RealTime, video colposcopy, cervical biopsy by the method of loop excision or conization.
Results
During 2008 - 2018 released 23 newsletters and the booklet were put out, 5 round tables were held for the female population of RO on the etiology and treatment of cervical cancer, the possibilities of vaccination in RCCP. From 2014 to 2017, 188 641 cytological studies were performed, CC being revealed in 189 women - 0.1 % , H-SIL and ASCH in 566 (0.3 %), ASCUS in 377 (0.2%), L-SIL in 23014 (12.2%), absence of intracellular lesion or malignancy (NILM) in 164495 (87.2%). 2162 HPV – positive women aged 19 to 69 years were invited to see a gynecologist in the RCCP. Treatment with conization (622) and cervical excision (830) was performed in 1452 patients. H-SIL and CIS in 1162 women (78%).
Conclusions
Regional screening program with an active call of patients, using such diagnostic method as liquid base cytology and HPV testing, allow timely detection and treatment of precancerous lesions of the cervix, i.e. to carry out secondary prevention of cervical cancer.